Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Tribute Pharmaceuticals Canada Inc. (TBUFF)

-Other OTC
0.62 Up 0.01(1.64%) Apr 17, 3:54PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 12,650   12,396   3,801  
Cost of Revenue7,005  7,205  1,417  
Gross Profit 5,644   5,191   2,383  
Operating Expenses
Research Development -   -   -  
Selling General and Administrative9,252  8,909  2,980  
Non Recurring -   -   -  
Others1,173  722  77  
Total Operating Expenses -   -   -  
Operating Income or Loss (4,780) (4,440) (674)
Income from Continuing Operations
Total Other Income/Expenses Net(1,206)45  (798)
Earnings Before Interest And Taxes(5,986)(4,395)(1,472)
Interest Expense496  254   -  
Income Before Tax(6,482)(4,649)(1,472)
Income Tax Expense(296)(1,286)(959)
Minority Interest -   -   -  
Net Income From Continuing Ops(6,770)(3,363)(512)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (6,186) (3,363) (512)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (6,186) (3,363) (512)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.